ICIrene Y. Chen

Irene Y. Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irene Y. Chen has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Adel K. El-Naggar

    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

    2 shared publications
  • Apeksha Chaturvedi

    Division of Pediatric Radiology, Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USA

    2 shared publications
  • Maria Clara Lorca

    Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY

    2 shared publications
  • Mark G. Ettel

    Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA

    2 shared publications
  • Moises J. Velez

    From the Department of Imaging Sciences, University of Rochester Medical Center, 601 Elmwood Ave, Box 648, Rochester, NY 14642 (M.C.L., G.J., S.P., Apeksha Chaturvedi, Abhishek Chaturvedi); Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, NY (I.C., M.J.V.); Department of Radiology, Montefiore Medical Center, New York, NY (A.C.F.); and Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Conn (L.B.H.).

    2 shared publications
  • Xiaoyan Liao

    University of Rochester Medical Center

    2 shared publications

Latest Publications

  • Lithium Therapy–Associated Thyroid Alterations Mimicking Thyroid Malignancy: A Diagnostic Pitfall

    by Irene Y. Chen, Adel K. El-Naggar

    Lithium is a commonly used mood stabilizer in managing bipolar disorder. While its therapeutic benefits are well-documented, its potential to induce thyroid-related disorders has long been recognized. Hypothyroidism is the most common thyroid dysfunction associated with lithium, though lithium-induced thyroiditis remains a rare and often overlooked complication. In this report, we describe a thyroid nodule initially diagnosed as “high-grade thyroid carcinoma” due to severe histomorphologic changes at an outside institution, which was later reclassified at our review as an iatrogenic effect of long-term lithium therapy. Preoperative fine needle aspiration, interpreted as “atypical follicular neoplasm (Bethesda Category IV),” prompted a diagnostic right lobectomy. No molecular testing was performed. The lobectomy was misinterpreted as carcinoma, leading to completion thyroidectomy. Histologic features included intersecting fibrosis, patchy lymphocytic inflammation, hyperplastic changes with pseudopapillary formation, nuclear pleomorphism with hyperchromasia, and giant cell formation, but notably absent were mitotic activity and necrosis, which are required for poorly differentiated or differentiated high-grade thyroid carcinoma under the 2022 WHO criteria. The patient's long history of lithium therapy was instrumental in recognizing the functional origin of the thyroid changes, which, if identified earlier, could have prevented unnecessary completion surgery. This report highlights the evolving diagnostic criteria for thyroid tumors, illustrating how lithium-associated thyroiditis can mimic malignancy and lead to overtreatment if historical context is not considered.


  • Open Access

    Distant Pulmonary Metastasis in Microsecretory Adenocarcinoma of the Salivary Gland: A Case Report Highlighting Histological Variation and Aggressive Potential

    by Aneeza Irfan, Irene Y Chen, Chrysa Stamou, Sandra Hürlimann, Tamara Rordorf, Sandra Freiberger, Hamza Irfan, Niels Rupp, Mena Mansour

    Microsecretory adenocarcinoma (MSA) is a rare, recently defined, low-grade salivary gland neoplasm characterized by a recurrent MEF2C::SS18 gene fusion and a generally indolent clinical course. Most tumors arise in the oral cavity, particularly the hard palate and buccal mucosa, and display microcystic and tubular architecture with bland cytological features and a consistent immunoprofile, including SOX10, S100, and p63 positivity, while p40 is negative. To date, fewer than 50 patients have been reported, with only 2 demonstrating high-grade histological features or distant metastasis. Herein, we report a 34-year-old woman with a tumor of the retromolar trigone, initially classified as polymorphous adenocarcinoma. Fifteen years later, the patient developed pulmonary metastases with distinct histomorphological features, including solid-cribriform differentiation and comedo-type necrosis. Molecular analysis identified an MEF2C::SS18 gene fusion and an immunohistochemical profile consistent with MSA. This report highlights the histological variation and the potential for late metastatic progression in MSA, emphasizing the need for accurate molecular diagnosis and long-term clinical surveillance, even in tumors that appear histologically low-grade at initial presentation.


  • Margin clearance and post‐procedure ablation decrease recurrence risk in endoscopic mucosal resections for Barrett's‐related neoplasia

    by Phoenix D Bell, Vivek Kaul, Krystle M Bittner, Irene Y Chen, Aaron R Huber, Olivia A Sagan, Wei Chen, Ilke Nalbantoglu, Raul S Gonzalez

    Aims: Endoscopic mucosal resection (EMR) is widely used for treating Barrett's‐related oesophageal dysplasia and low‐stage carcinoma. Disease can recur after this procedure. We analysed a large cohort of EMR specimens to assess clinical and histopathologic factors and their relationship to recurrence. Methods and results: We conducted a retrospective study of 129 patients who had in total 290 oesophageal EMRs for glandular neoplasia. Patient age, patient sex, specimen fragmentation, intestinal metaplasia, highest‐grade lesion, margin status and clearance, cancer invasion depth, lymphovascular invasion, tumour budding (using published guidelines for colorectal carcinoma), post‐procedure cryoablation/radiofrequency ablation and disease recurrence were recorded. Statistical analyses were performed on 227 eligible cases to determine the significance of these factors in local disease recurrence. Adenocarcinoma was the highest‐grade lesion in 42% of the 290 specimens, high‐grade dysplasia in 36% and low‐grade dysplasia in 22%. Mean age at first EMR was 66 years. Among the 227 statistically analysed cases, post‐procedure ablation was performed for 111 (49%) and recurrence of same or worse disease was documented in 104 (46%). Tumour depth and budding did not affect recurrence risk. On multivariate analysis, lack of post‐procedure ablation was associated with increased recurrence risk for high‐grade dysplasia and carcinoma. Additionally, poor differentiation and margin status were associated with increased recurrence risk for specimens with carcinoma. These relationships mostly held true for recurrence of same/worse neoplasia or recurrence of any neoplasia. Conclusions: Differentiation, margin status and post‐EMR ablation influence the risk of local disease recurrence for Barrett's‐related adenocarcinoma, while other factors such as tumour budding and lesional depth do not.


  • Comparative transcriptomics of salivary basal cell adenoma and adenocarcinoma sustain linear neoplastic evolution and intertumor heterogeneity: classification and biological implications

    by Yoshitsugu Mitani, Haneen Al‐Maghrabi, Tatiana V Karpinets, Raissa T Relator, Lauren Hilder, Irene Y Chen, Ryan P Goepfert, Diana Bell, Jianhua Zhang, Renata Ferrarotto, et al.

    It remains uncertain whether basal cell adenoma (BCA) and basal cell adenocarcinoma (BCAC) of the salivary gland represent two distinct neoplasms or temporal stages of a single entity. The issue is central to reconciling their shared phenotypic resemblance and protracted behavior with current pathologic classification. We conducted a transcriptomic analysis on a cohort of both pathologic forms and correlated the findings with the clinicopathologic features using RNA extracted from fresh frozen samples of 25 salivary basal tumors (five BCAs and 20 BCACs) and eight instances of metastatic basal cell carcinomas (BCCs) to parotid glands. Unsupervised analysis revealed shared and intertumoral transcriptome differences within and between BCA and BCAC and distinct segregation from metastatic dermal BCC. Transcriptomic profiling delineated two intermixed subgroups of salivary basal cell neoplasms (SBNs); SBN‐I group enriched with adverse pathologic features and SBN‐II that lacked any of these features except for a single case. The category with the most instances of adverse pathologic features (SBN‐I) manifested upregulations of transcriptional factors linked to cell proliferation pathways (HOXB13, SOX21, MYB, and EN1 genes), while those lacking adverse pathologic features (SBN‐II) demonstrated a high expression of the TFAP2B transcription‐ and differentiation‐related pathways. Our transcriptomic findings support common neoplastic evolution and intertumoral heterogeneity of both pathologic forms of basal cell neoplasms and identify molecular pathways of potential biological and clinical significance. We therefore propose a nondeterministic designation of ‘basal cell salivary neoplasms, noninvasive (adenoma)/invasive (adenocarcinoma)’ as a platform that integrates conventional phenotypic classification and transcriptomic characteristics pending a classification consensus. © 2025 The Pathological Society of Great Britain and Ireland.

  • Radiologic-Pathologic Correlation of Cardiac Tumors: Updated 2021 WHO Tumor Classification

    by Maria Clara Lorca, Irene Chen, Gregory Jew, Andrea C. Furlani, Savita Puri, Linda B. Haramati, Apeksha Chaturvedi, Moises J. Velez, Abhishek Chaturvedi

    Cardiac tumors, although rare, carry high morbidity and mortality rates. They are commonly first identified either at echocardiography or incidentally at thoracoabdominal CT performed for noncardiac indications. Multimodality imaging often helps to determine the cause of these masses. Cardiac tumors comprise a distinct category in the World Health Organization (WHO) classification of tumors. The updated 2021 WHO classification of tumors of the heart incorporates new entities and reclassifies others. In the new classification system, papillary fibroelastoma is recognized as the most common primary cardiac neoplasm. Pseudotumors including thrombi and anatomic variants (eg, crista terminalis, accessory papillary muscles, or coumadin ridge) are the most common intracardiac masses identified at imaging. Cardiac metastases are substantially more common than primary cardiac tumors. Although echocardiography is usually the first examination, cardiac MRI is the modality of choice for the identification and characterization of cardiac masses. Cardiac CT serves as an alternative in patients who cannot tolerate MRI. PET performed with CT or MRI enables metabolic characterization of malignant cardiac masses. Imaging individualized to a particular tumor type and location is crucial for treatment planning. Tumor terminology changes as our understanding of tumor biology and behavior evolves. Familiarity with the updated classification system is important as a guide to radiologic investigation and medical or surgical management. ©RSNA, 2024 Supplemental material is available for this article.


  • SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study

    by Irene Y. Chen, Mark G. Ettel, Phoenix D. Bell, Aaron R. Huber, Jennifer J. Findeis-Hosey, Wenjia Wang, Aram F. Hezel, Richard F. Dunne, Michael G. Drage, Diana Agostini-Vulaj


  • Clinicopathological spectrums and prognosis of primary appendiceal adenocarcinoma, goblet cell adenocarcinoma, and low-grade appendiceal mucinous neoplasms

    by Irene Chen, Xiaoqin Liu, Sierra Kovar-Peltz, Stephanie J. Conrad, Hannah H. Chen, Xiaoyan Liao


  • Ameloblastic Carcinoma of the Maxilla: A Rare Case Report and Review of Literature from 1948 to 2021

    by Irene Y. Chen, Ellen J. Giampoli, Dongwei Zhang

    Ameloblastic carcinoma is a rare malignant neoplasm arising from the odontogenic epithelium. Ameloblastic carcinoma commonly occurs de novo affecting the posterior segments of the mandible. Presently, only less than 100 cases have been reported arising from the maxilla. We report a unique case of maxillary ameloblastic carcinoma in a 68-year-old male with a 5.6 cm positron emission tomography (PET) avid left maxillary sinus mass. The patient underwent a left maxillectomy which revealed hyperchromatic and pleomorphic tumor cells arranged in a nested and trabecular architecture. The tumor cells showed distinct peripheral palisading with reverse polarization. Areas of bone destruction, necrosis, lymphovascular and perineural invasions, as well as atypical mitoses, were identified. Immunohistochemically, the tumor cells were positive for keratin cocktail (AE1/AE3 and CAM 5.2), keratin 19, p40, and weakly positive for MDM2, while negative for calretinin. Molecular analysis revealed wild-type BRAF; however, alterations in CDKN2A/ B, MTAP, RB1, SMARCA4, STK11, FGF12, SETD2, and TP53 were present. This histopathologic and molecular profile supported the diagnosis of ameloblastic carcinoma. There has been no evidence of disease recurrence or metastasis eleven months after the initial diagnosis.


  • Imaging and Clinical Findings in a Series of Six Cases of Rare Primary Mediastinal Liposarcoma

    by Gordon S. Wong, David Bass, Irene Y. Chen, Raymond Thomas, Moises J. Velez, Susan K. Hobbs

    Primary mediastinal liposarcomas are rare mediastinal tumors, so it is important for radiologists and clinicians to be familiar with the clinical presentation, radiographic characteristics, managem... Primary mediastinal liposarcoma is a rare, fat-containing malignant lesion that can manifest incidentally with varied imaging appearances. The size and location within the mediastinum can vary amon...